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A B S T R A C T
Identiﬁcation of transformationproducts (TPs) of emerging pollutants is challenging, due to the vast number
of compounds, mostly unknown, the complexity of the matrices and their often low concentrations, re-
quiringhighly selective, highly sensitive techniques.Wecompile background informationonbiotic andabiotic
formation of TPs and analytical developments over the past ﬁve years. We present a database of biotic or
abiotic TPs compiled from those identiﬁed in recent years.We discussmass spectrometric (MS) techniques
and workﬂows for target, suspect and non-target screening of TPs with emphasis on liquid chromatogra-
phy coupled to MS (LC-MS). Both low- and high-resolution (HR) mass analyzers have been applied, but
HR-MS is the technique of choice, due to its high conﬁrmatory capabilities, derived from the high resolving
power and the mass accuracy in MS and MS/MS modes, and the sophisticated software developed.
© 2014 Elsevier B.V. All rights reserved.
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1. Introduction
The term “emerging pollutants” (EPs) [or “emerging contami-
nants” (ECs)] refers to compounds and their metabolites that are
not currently covered by existing water-quality regulations, have
not been studied often, are overlooked and are thought to be
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potential threats to environmental ecosystems and human health
and safety. According to NORMAN (Network of reference labora-
tories, research centers and related organizations for monitoring
emerging environmental substances), they are compounds that are
not included in routine environmental monitoring programs and
may be candidates for future legislation due to their adverse effects
and/or persistency (http://www.norman-network.net/). Most regu-
lating and implementation bodies, responsible for water and
wastewater treatment, are working on the assumption that the so-
called priority pollutants are responsible for the most signiﬁcant
share of environmental, human health and economic risk, even
though they represent a minor fraction of the universe of known
and yet-to be identiﬁed chemicals [1].
EPs encompass a diverse group of compounds, including phar-
maceuticals and personal-care products (PPCPs), drugs of abuse
(DoAs) and their metabolites, steroids and hormones, endocrine-
disrupting compounds, surfactants, perﬂuorinated compounds,
phosphoric ester ﬂame retardants, industrial additives and agents
(e.g., benzotriazoles and benzothiazoles), siloxanes, artiﬁcial sweet-
eners, and gasoline additives.
Once released into the environment, EPs are subject to biotic
and abiotic transformation processes that are responsible for their
transformation and/or elimination, according to their persistence,
transport, and ultimate destination. Various transformations can
take place, producing compounds that, to some extent, differ in
their environmental behavior and ecotoxicological proﬁle from
the parent compound. Formation of transformation products (TPs)
occurs mainly through oxidation, hydroxylation, hydrolysis, con-
jugation, cleavage, dealkylation, methylation and demethylation.
EPs and their TPs can move vertically through the soil proﬁle to
groundwater and away from the source site with mobile ground-
water. They also have the potential to reach surface water when
they travel laterally as surface run-off or through sub-soil tile
drains, entering streams, major rivers, reservoirs, and ultimately
estuaries and oceans [2].
Since there is a gap in the information on the occurrence and
the toxicity of TPs in the environment, we are unable to evaluate
their signiﬁcance in risk assessment [3,4]. Standardized toxicity tests
can provide quantitative information on the toxicity of the TP, com-
pared to its parent compound, but these studies are limited [5–7].
In general, TPs are less toxic and more polar than the parent com-
pounds. However, in some cases, they may be more persistent or
exhibit higher toxicity or be present at much higher concentra-
tions [8].
Although there is legislation regulating chemicals [e.g., pesti-
cides, veterinary drugs, and persistent organic pollutants (POPs)],
there is little mention of their TPs. Concerns over the TPs of pes-
ticides in plants have been expressed since 1991 (European Directive
91/414/EEC), while the term “metabolite” appears in Regulation (EC)
1107/2009, concerning plant-protection products, and in Direc-
tives 2001/82/EC and 98/8/EC, concerning veterinary medical and
biocidal products, respectively. European Medicines Agency (EMEA,
2006) also referred to the need for assessment of potential envi-
ronmental risks of humanmedicinal products. However, in all these
documents, there is no clariﬁcation on the determination, limits and
toxicological effects of metabolites or TPs.
In OECD guidelines, concerning the Aerobic and Anaerobic Trans-
formation in Aquatic Sediment Systems, adopted in 2002, it is
claimed that TPs detected at ≥10% of the applied radioactivity
should be identiﬁed. Meanwhile, EU Regulation 1907/2006 (REACH)
requires identiﬁcation of major TPs and degradation products for
the registration of the substance. In the Regulation (EC) 850/2004
on POPs, a reference to their transformation processes also
exists.
There is therefore a clear need to reveal the qualitative and quan-
titative occurrence of TPs in the environment, but this is only possible
with continual development of instrumental analysis. Thereby, the
range of identiﬁable chemicals is extended, and the quantiﬁcation
limits are lowered. With respect to obtaining a holistic view of risk,
target-based environmental monitoring should be accompanied by
non-target analysis using high-resolution (HR) hybrid mass spec-
trometers. The development of these highly resolved, accurate,
hybrid, tandem mass spectrometers, and improved sophisticated
software, has enabledmore reliable, selective target analysis of highly
polar compounds, and screening for unknown pollutants. The major
beneﬁt of full-scan and HR, accurate MS is that, within a single an-
alytical run, target, suspect and non-target compounds can be
analyzed or identiﬁed.
In the analysis of EPs, HR mass spectrometry (HR-MS) has been
widely reported [3,9–12]. Moreover, for identiﬁcation of TPs in en-
vironmental, food and biological samples, hybrid HRmass analyzers
[e.g., linear ion trap Orbitrap MS and quadrupole time-of-ﬂight MS
(Q-TOF)] have been used, following speciﬁc workﬂows [12–16]. More
speciﬁcally, human and microbial metabolites, oxidation and
photodegradation TPs of pharmaceuticals have been discussed often
[17–21]. Similarly, TPs of pesticides in biological (human metabo-
lism, phase II), food and environmental samples have been reviewed
[22,23]. Furthermore, the TPs of anthelmintics [24], UV ﬁlters in the
environment [25,26] and steroidal compounds in biological samples
[27] are included in recent review papers. An interesting fact con-
cerning the analysis of EPs and their TPs is enantioselective
biotransformation. Chiral EPs or chiral TPs formed may have
enantioselective activity or toxicity, making chiral chromatogra-
phy indispensable [28].
Achievements, future trends and new developments in the anal-
ysis of EPs and their TPs were summarized by Farré et al. [29] and
Fisher et al. [30]. Recently, highly sophisticated, comprehensive, step-
wise workﬂows were also presented by Moschet et al. [31] and Hug
et al. [32] for suspect and non-target screening of pesticides and
EPs, including TPs in their suspect lists. However, it is still chal-
lenging to proﬁle TPs in environment samples, since they are formed
throughmany possible reactions, automatic workﬂows for the iden-
tiﬁcation are not readily available, so manual data inspection is
necessary, though time consuming, and, ﬁnally, there are no stan-
dards available.
The aim of this review is to compile the recent information re-
garding the background of (biotic and abiotic) transformation of EPs.
We provide a brief overview of existing literature on transforma-
tion studies under biotic and abiotic conditions in recent years and
we compile a list of all the EPs studied and comprehensive infor-
mation for researchers in the ﬁeld. We brieﬂy summarize target
analysis, since the development of accurate mass instruments and
sophisticated computer tools has led to suspect and non-target anal-
ysis, even though all three procedures are indispensable parts of an
integrated approach to determination of EPs and their TPs. We
present the design of laboratory studies to facilitate identiﬁcation
of TPs by LC-MS and appropriate sample preparation. We thor-
oughly discuss target, suspect and non-target workﬂows using HR-
MS/MS to identify new TPs.
2. Classiﬁcation of transformation products (TPs)
TPs occurring in the environment can be classiﬁed into twomain
categories: biotransformation products formed by biotic or abiotic
processes. This classiﬁcation has subcategories that we describe in
detail below, emphasizing the aquatic environment. The biotrans-
formation products include human, animal andmicrobial metabolites
in engineered and natural systems. The abiotic TPs are the outcome
of hydrolysis, photolytic and photocatalytic degradation in the natural
environment and water-treatment processes (e.g., chlorination,
ozonation and advanced oxidation).
33A.A. Bletsou et al./Trends in Analytical Chemistry 66 (2015) 32–44
2.1. Transformation products formed by biotic reactions
TPs are formed by microbial activities in natural and engi-
neered environmental compartments, such as soil, surface water or
wastewater treatment. Enzymatic reactions are involved in micro-
bial transformation [such as, oxidation (e.g., hydroxylation, N- and
S-oxidation, and dealkylation) and reduction (e.g., dehalogenation,
nitro reduction, and hydrolysis of amides and carboxyl esters)]. As
mentioned, pharmaceuticals, drugs of abuse and other chemicals
consumed by humans and other mammals can be metabolized and
then released into the environment as metabolites. For mammals,
besides oxidation and reduction, conjugation reactions also occur
with endogenous molecules, such as carbohydrates, sulfate, gluta-
thione and amino acids.
Some environmental pollutants are signiﬁcantly accumulated and
subsequently transformed in wildlife. In particular, aquatic organ-
isms are considered the primary receptors, and might show
qualitatively and quantitatively different metabolic pathways com-
pared to microbes and humans. Hence, the metabolites formed in
aquatic organisms and their toxicity are of increasing ecotoxicological
concern.
In the sections below, we discuss biotransformation products,
classiﬁed into three groups, and we present ﬁndings from recent
studies, with a clearly stated identiﬁcation workﬂow in Table 1.
Table S1 (Supplementary Material) shows an extensive list of all the
biotransformation products of EPs presented so far in the literature.
2.1.1. Transformation products formed by microbial metabolism
Due to the increasing occurrence of EPs in wastewaters, the for-
mation of TPs during biological treatment and the mechanisms
involved have been investigated for various classes of compounds
{i.e., antibiotics [35,45,54], analgesics (painkillers) [39],
anticonvulsants [37], anti-inﬂammatories [40,41], iodinated X-ray
contrast media (ICM) [46,47] and anti-viral/-bacterial/-fungal agents
[33,56,57]}. Most of the studies were performed in batch systems
with activated sludge.
In almost all the studies, oxidative reactions, such as hydrox-
ylation, oxidation, and dealkylation, were observed as the primary
biotransformationmechanisms. Hydroxylatedmetabolites were iden-
tiﬁed for triclosan [57], codeine [39], diclofenac [40,41], sulfapyridine
[54], and a UV ﬁlter [48]. In some cases, oxidation of hydroxyl groups
was followed by oxidative decarboxylation, deacetylation, and
dealkylation taking place at the amide moieties [33,46,47]. Mol-
ecules with N-, O-, or S-alkyl groups were probably transformed to
dealkylated forms, as observed for naproxen [53], triclosan [57],
diclofenac [41] and ICM [46,47]. Other oxidative reactions in-
cluded ring opening, oxidative deamination and oxidative
dechlorination [34,45,50,56].
Helbling et al. intensively investigated microbial transforma-
tion of 30 xenobiotic compounds with amide groups and observed
53 TPs resulting from amide hydrolysis, N-dealkylation, hydrox-
ylation, oxidation, dehalogenation, glutathione conjugation andmany
more pathways [34]. Moreover, the hydrolysis rate and the domi-
nant reaction related to the degree of alkyl substitution of the amide
group.
Other studies investigated predictive factors of the biotransfor-
mation reactions. Ammonia removal and ammonia monooxygenase
(amoA)-transcript abundance can be associated with oxidative
micropollutant-biotransformation reactions, without necessarily
being catalyzed by amoA [58].
Meanwhile, reduction reactions predominantly take place under
anaerobic conditions, such as reductive dechlorination of
5-chlorobenzotriazole and chlorpromazine and dehydration and hy-
dration of testosterone [38,55]. However, nitro reduction of N,N-
diethyl 1–4-nitrobenzamide was evident under aerobic conditions
in a recent study [34].
Apart from common oxidation and reduction, other reactions,
such as decarboxylation and deacetylation, were reported less fre-
quently [46,47]. In addition, conjugation reactions, such as
phosphorylation, succinylation and glutathione substitution, are also
possible biotransformation mechanisms [34,45].
The biodegradability of perﬂuorinated compounds (PFCs) at-
tracts the interest of scientists. A number of studies presented the
degradability and the fate of PFC precursors, such as ﬂuorotelomer
alcohols in sediments resulting in perﬂuorinated carboxylic acids
[43,44]. Nevertheless, no TPs of perﬂuoroctanoate (PFOA) have been
reported, stressing that these compounds are very stable and hardly
degradable [59,60].
2.1.2. Transformation products (metabolites) formed by human
metabolism
Even though human metabolites of PPCPs and their mecha-
nisms of formation have been extensively studied in pharmacology,
limited information on their occurrence and stability in the envi-
ronment is available. However, human and microbial metabolisms
partly present the samemetabolic reactions and thus the sameme-
tabolites, so their discrimination in environmental samples is
sometimes diﬃcult. Kern et al. stated that six pharmaceutical TPs
found in surface-water samples were known human metabolites
of metamizole, aminopyrine, carbamazepine and verapamil from
registration ﬁles [51]. However, four of these six metabolites were
formed through epoxidation, dihydroxylation and O-demethylation,
which can also take place inmicrobial metabolism. Perez and Barceló
reported that hydroxylation products of diclofenac and aceclofenac,
known as both human and microbial metabolites, were measured
in wastewater samples [41].
Mass balances of inﬂuent and eﬄuent samples can clarify the
origin of the TPs in more detail. In the tiered approach proposed
by Kern et al., batch experiments with activated sludge can be used
to verify the ﬁndings and to quantify transformation rates [52].
For estrogenic compounds, the metabolites formed are glucuro-
nide and sulfate conjugates and are frequently detected in untreated
wastewaters [61]. However, the conjugated estrogens are vulner-
able in aerobic activated sludge and end up as free estrogens after
de-conjugation [62]. The de-conjugation behavior is also ob-
served for pharmaceuticals, resulting in negative removal eﬃciencies
[63,64]. However, deconjugation reactions happen with different re-
action rates. For example, for estrogens, sulfate conjugates are
reported to be more persistent than glucuronides. In case of
lamotrigine, N-glucuronide metabolite has frequently been de-
tected inwastewater, surface-water and groundwater samples, unlike
O-glucuronide, due to the difference in degradability of O- and
N-glucuronide products [65].
2.1.3. Transformation products formed in wildlife
EPs are ubiquitous in the environment due to their low
degradability, and probably accumulate in biota (bioaccumulation)
and sediments. Biotransformation in organisms, as a subsequent
process of bioaccumulation, is of great interest in order to clarify
the fate and the toxicity of those compounds and their TPs. However,
studies of drug metabolism in ﬁsh are extremely limited and the
metabolic pathway and enzymes responsible for the metabolism
of the drugs in ﬁsh are largely unknown [66].
Moreover, metabolites of POPs have been measured in various
tissues (e.g., blood, blubber, fat, and bird eggs) and in marine or-
ganisms (including ﬁsh), but, in many cases, it is not known if the
compounds formed are the result of in-vivo metabolism or are
bioaccumulated from the environment [67].
In a study, oxidation reactions in vitro were hindered by the in-
creased number of bromine substituents and hydroxylated
metabolites and oxidative bond-cleavage products are formed in ﬁsh
34 A.A. Bletsou et al./Trends in Analytical Chemistry 66 (2015) 32–44
Table 1
Identiﬁed biotransformation products of emerging contaminants in the aquatic environment
Parent compound/Group of
substances
(Bio)assay/Test organism/
Degradation system
Identiﬁed TPs/Transformation
reaction
Toxicity
Information
Identiﬁcation workﬂow Ref.
Sample
preparation
Instrumental
technique(s)
Software (prediction/
post data treatment)
Acyclovir (ACV), Penciclovir (PCV) Batch systems seeded with
activated sludge
ACV: carboxy-ACV, PCV: 8 TPs
(oxidation)
– SPE (Isolute ENV+) HPLC-LTQ-Orbitrap-MSn,
1D & 2D NMR
UM-PPS, Thermo XCalibur,
fragmentation pattern
[33]
30 Amide-containing compounds Batch system seeded with sludge
from a pilot-scale membrane
bioreactor
53 TPs: amide hydrolysis and
N-dealkylation, hydroxylation,
oxidation, ester hydrolysis,
dehalogenation, nitro reduction, and
glutathione conjugation/kinetic study
– – LC-MS Orbitrap, data
dependent MS/MS
acquisition
UM-PPS, Thermo XCalibur,
post-acquisition data
processing of the full-scan
MS data (mass accuracy,
isotope matching and MS/
MS evaluation)
[34]
Amoxicillin Laboratory alkaline & acidic
hydrolysis study with
wastewater and river water
4 TPs: b-lactam ring cleavage – SPE (OASIS™HLB) LC/QTOF-MS/MS Agilent MassHunter
Workstation, mass
accuracy, XIC,
fragmentation pattern
[35]
Benzotriazoles: 1H-BTR
5-CH3-BTR
4-CH3-BTR
Batch studies under aerobic
conditions with sludge
42 candidate TPs – 4 conﬁrmed TPs:
1-CH3-BTR, 4-OH-BTR, 5-OH-BTR (from
1H-BTR) and 5-COOH-BTR (from 5-CH3-
BTR). Hydroxylation at the benzene ring
was the major pathway
– – LC-MS Orbitrap, data
dependent MS/MS
acquisition
Suspect screening after
UM-PPS, non-target
screening; Thermo
XCalibur, post-acquisition
data processing of the full-
scan MS data; In silico
fragmentation by MetFrag;
MOLGEN-MS/MS for
structure annotation
[36]
Carbamazepine Aqueous medium from air
pulsed ﬂuidized bioreactor and
from culture broth
Acridone, acridine, 10,11-dihydro-10,11-
epoxycarbamazepine & dihydroxy-
carbamazepine
Acute toxicity
test: Vibrio
ﬁscheri
luminescence
reduction:
nontoxic
SPE (OASIS™HLB) UPLC/ESI-QqToF -
HPLC/ESI-QqLIT -
Waters MassLynx, XIC,
mass accuracy,
fragmentation pattern
[37]
Chlorpromazine (tricyclic
antipsychotic drug)
OECD: Closed Bottle test,
Manometric
Respirometry test, modiﬁed
Zahn–Wellens test, anaerobic
test
TPs: 3 aerobic & 1 anaerobic
(hydroxylation, demethylation,
acetylation)
neither readily
nor inherently
biodegradable
– toxic to
anaerobic
sludge
– HPLC-UV-Fluorescence–
IT MSn
fragmentation & isotopic
pattern, Bruker Esquire
software, Metabolite
Detect (Metabolite Tools),
Data Analysis
[38]
Codeine (Opium Alkaloid) Aerobic batch experiments
seeded with activated sludge
8 TPs: double bond shifts, introduction
of hydroxy groups, amine demethylation
– transformation pathways suggested
for structurally related opium alkaloids
(morphine & dihydrocodeine)
– SPE (OASIS™MCX) HPLC-LTQ-Orbitrap-MSn
& HPLC-Qq-LIT-MS, data
dependent acquisition,
1D & 2DNMR
fragmentation pattern,
Thermo Xcalibur
[39]
Diclofenac fungus Trametes versicolor – in
vivo and in vitro experiments
with cytochrome P450 and
laccase
4-hydroxydiclofenac,
5-hydroxydiclofenac (hydroxylation) &
4-(2,6-dichlorophenylamino)-1,3-
benzenedimethanol
Decrease in
ecotoxicity
(Microtox test)
– HPLC-UV, NMR – [40]
Diclofenac, Aceclofenac pilot MBR 3 novel TPs: nitrosation, nitration,
N-dealkylation and carboxylation
– SPE (Oasis™ HLB,
Isolute ENV+)
HPLC/ESI-QqLIT-MS,
UPLC/ESI-QqTOF-MS,
H/D-Exchange
Experiments
fragmentation pattern,
Waters MassLynx
[41]
Flame retardants: 4,4-
dibromodiphenyl ether (BDE 15),
2,2,4,4-tetrabromo-diphenyl
ether (BDE 47), tetrabromo-
bisphenol A (TBBPA)
in vitro – liver microsomes and
S9 fractions of crucian carp
BDE 15: Bromophenol,
2monohydroxylateddibromodiphenyl
ethers
TBBPA: 2,6-dibromo-4-isopropyl-phenol
– LLE HPLC-QqQ-MS/MS, GC-
IT-MS/MS
fragmentation pattern,
Thermo XCalibur
[42]
Fluorotelomer alcohols (6:2 FTOH) Batch study with river sediment 5:3 acid, PFPeA, PFHxA, and PFBA, 5:2
sFTOH
– ENVI™-Carb
(graphitized carbon)
LC-MS/MS (QqQ) -SRM
technique
– [43]
(continued on next page)
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Table 1 (continued)
Parent compound/Group of
substances
(Bio)assay/Test organism/
Degradation system
Identiﬁed TPs/Transformation
reaction
Toxicity
Information
Identiﬁcation workﬂow Ref.
Sample
preparation
Instrumental
technique(s)
Software (prediction/post
data treatment)
5:3 Polyﬂuorinated acid (major TP
of 6:2 FTOH & 8:2 FTOH)
Activated sludge 4:3 acid, 3:3 acid, one-carbon removal
pathways(-CF2-), perﬂuoropentanoic
acid (PFPeA), perﬂuorobutanoic acid
(PFBA)
– C18 cartridge, ENVI™-
Carb
HPLC-LTQ Orbitrap MS/
MS
Mass defect data ﬁltration,
mass accuracy
[44]
Fluoroquinolones (norﬂoxacin,
ciproﬂoxacin) Macrolides
(azithromycin, erythromycin,
roxitromycin)
Wastewater eﬄuents from
Zenon hollow-ﬁber membrane
bioreactor (MBR)
ﬂuoroquinolones: conjugate compounds
formed by phosphorylation, (phase II
metabolites) macrolides: conjugates
formed by succinylation of the
piperazine ring & smaller metabolites
formed by oxidative break-up of
piperazine moiety
– SPE (OASIS HLB) UHPLC-QTOFMS, MS/MS
acquisition
Waters MassLynx [45]
Iodinated X-ray Contrast Media
(iohexol, iomeprol, iopamidol)
Batch reactor seeded with
secondary wastewater eﬄuents
27 TPs: oxidation, oxidative
decarboxylation, deacetylation, cleavage
at the amide moieties
– SPE (Isolute ENV+) HPLC-Qq-LIT-MS, MS/MS,
NMR
fragmentation pattern [46]
Iodinated X-ray Contrast Media
(diatrizoate, iohexol, iomeprol,
iopamidol)
Aerobic soil-water and river
sediment-water batch systems
7 novel TPs: Oxidation, cleavage of N-C
bonds and decarboxylation
- - HPLC-Qq-LIT-MS, MS/MS fragmentation pattern [47]
4′-methylbenzylidene- camphor
(4-MBC)
Fungus Trametes versicolor Hydroxylated and pentose-conjugated
TPs
No endocrine
disruption and
dioxin-like
activity
Pressurized liquid
extraction (PLE)
UPLC-QqTOF-MS/MS fragmentation pattern,
Waters MassLynx
[48]
Metformin Closed Bottle test, Manometric
Respiratory test, Zahn–Wellens
test with activated sludge
Guanyl urea (dealkylation & oxidative
deamination)
– – HPLC-Ion Trap MSn Bruker Esquire [49]
6 Pharmaceuticals & 6 Pesticides
(atenolol, bezaﬁbrate, diazepam,
levetiracetam, oseltamivir,
valsartan & carbetamide,
clomazone, DEET, napropamide,
propachlor, tebutam)
Batch reactors seeded with
activated sludge
21 TPs from suspect screening & 26 TPs
from non-targeted screening
– – HPLC-LTQ-Orbitrap, data
dependent MS/MS
acquisition
UM-PPS (suspects),
Thermo XCalibur, detailed
post-acquisition data
processing of the full-scan
MS data (target screening,
non-target screening)
[50]
52 Pesticides, Biocides,
Pharmaceuticals
Surface water 19 plausible TPs identiﬁed – SPE (100 mg Strata-X-
AW, 100 mg
Strata-X-CW, 150 mg
Isolute ENV+, 200 mg
Oasis HLB)
HPLC-LTQ-Orbitrap MS/
MS
UM-PPS, Thermo Xcalibur,
Mass Frontier, mass
accuracy, fragmentation
pattern, isotopic pattern
[51]
Pharmaceuticals: atenolol,
bezaﬁbrate, ketoprofen,
metoprolol, ranitidine, valsartan,
venlafaxine, carbendazim
Sludge-seeded batch reactors 12 TPs – SPE (Strata-X-AW,
Strata-X-CW, Isolute
ENV+, Oasis HLB)
HPLC-LTQ-Orbitrap, data
dependent MS/MS
acquisition
UM-PPS, Thermo Xcalibur,
detailed workﬂow for the
identiﬁcation of
biotransformation
products
[52]
Acidic pharmaceuticals
(ketoprofen, bezaﬁbrate,
naproxen, ibuprofen, diclofenac)
Activated sludge as inocculum
under aerobic conditions
Ketoprofen: 2 novel TPs Bezaﬁbrate:
4-chlorobenzoicacid Naproxen:
O-desmethyl-naproxen Ibuprofen: 2
isomers of hydroxy-ibuprofen
– ion-pair solid phase
extraction (IP-SPE)
LC-ESI-MS/MS (QqQ),
Full scan MS, Product ion
scan, LC-UV
– [53]
Sulfapyridine Sulfathiazole Fluidized bed reactor with
Trametes versicolor seeded with
sterilized sewage sludge, in vitro
and in vivo assays with puriﬁed
laccase
7 TPs formylated and hydroxylated – – UPLC–QqTOF-MS mass accuracy,
fragmentation pattern
[54]
Testosterone Gamma proteobacterium
Steroidobacter denitriﬁcans
10 TPs (dehydrogenation,
hydrogenation)
– – HPLC-APCI-LTQ-Orbitrap,
MS/MS, LC-UV, LC – ion
trap – MS, NMR
mass accuracy,
fragmentation pattern
[55]
Triclosan laccase in aqueous systems 2,4-dichlorophenol (2,4-DCP),
dechlorinated forms of 2,4-DCP,
2-chlorohydroquinone
Detoxication by
enzymatic
transformation
– GC-IT-MS, HPLC-ESI-
QqQ, MS/MS, LC-UV
XIC [56]
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liver from 4,4′-dibromodiphenyl ether and tetrabromobisphenol A,
but not from higher brominated ﬂame retardants [42].
Recently, metabolites of polar organic pollutants formed in fresh-
water crustaceans, used in risk assessment, were identiﬁed [68,69].
Jeon et al. found 25 metabolites of irgarol, terbutryn, tramadol and
venlafaxine in Gammarus pulex and Daphnia magna, formed via ox-
idation reactions including N- and O-demethylation, hydroxylation,
N-oxidation and glutathione conjugation [68]. This shows the rel-
evance of metabolism in wildlife.
2.2. Transformation products formed by abiotic processes in aquatic
systems
Abiotic TPs are formed by water-treatment processes and in the
aquatic environment by hydrolysis and photolysis. Table 2 shows
research papers studying the formation of TPs from EPs under abiotic
conditions through one of the above processes, from the past three
years, with a clearly described identiﬁcation workﬂow. Table S2
(Supplementary Material) shows a more extensive list of studies.
Also, review papers provide information for TPs of antibiotics and
estrogens already identiﬁed, covering a wide range of abiotic pro-
cesses [76,77].
Oxidation processes, such as chlorination, chloramination,
ozonation, and advanced oxidation by UV/H2O2 treatment, are the
major processes used in advanced water treatment for disinfec-
tion and removal of ECs [8]. The oxidative reactionmechanisms often
rely on the formation of reactive, short-lived oxygen-containing in-
termediates, such as hydroxyl radicals (•OH). Generally, the TPs
formed correlate with the process conditions [e.g., the physico-
chemical properties of the matrix, and the speciﬁc conditions of
treatment (e.g., time and medium)].
Ozone is a strong oxidant that can be used as a more selective
agent for the removal of micropollutants. Ozonation may take place
by the direct reaction of the ozone molecule with the target com-
pound or by means of hydroxyl radicals produced from the
decomposition of ozone in aqueous media. In practice, both direct
and indirect reactions take place simultaneously. Ozone was re-
cently used as a fourth full-scale treatment step in wastewater
treatment [78]. Next to ozonation TPs, by-products formed by
oxidation of matrix components, such as carcinogenic
N-nitrosodimethylamine (NDMA) and bromate, have to be taken into
the cost-beneﬁt analysis of such technology [78].
Chlorination is a chemical process commonly used in water treat-
ment for disinfection. Inmost cases, chlorination is not applied when
oxidation of organic micropollutants is the goal, because it can
produce biologically active TPs [79]. Especially when the inorgan-
ic content in the water matrix is very high, some reactive species,
such as chloride or sulfate radicals, are produced, and they direct-
ly inﬂuence the formation of TPs. The chlorine radical (Cl•) may lead
to the formation of chlorinated organic compounds, which are known
to be very harmful, and, in some cases, able to generate persistent
substances [80]. In this disinfection process, hypochlorous acid (HClO)
is the reagent mainly responsible for pathogen destruction, but both
HClO and ClO− react with organic compounds, giving addition, sub-
stitution, or oxidation products. One of themajor concerns regarding
disinfection byproducts from chlorination is that NaClO is known
to produce genotoxic TPs and can thus increase the acute toxicity
[75].
Photochemistry represents an important degradation process in
the environment or as a light-related, advanced treatment of water.
Many studies have been carried out on direct and indirect photo-
lytic or photocatalytic degradation of EPs. For pesticides,
mineralization of pesticides by photocatalytic degradation has been
reported and the by-products and intermediates of organophos-
phate pesticides by photocatalytic degradation were recently
presented [81]. Pharmaceutical compounds [19,82], endocrine-
disrupting compounds [82], UV ﬁlters [83], and phenol [84] have
also been thoroughly surveyed for their fate and their TPs during
photolysis.
3. Identiﬁcation approaches – laboratory studies
Simulation of the transformation processes in batch experi-
ments under well-deﬁned conditions with appropriate controls is
a very common ﬁrst approach for the identiﬁcation of TPs. Batch
experiments can be applied under biotic and abiotic conditions at
high concentrations of the parent EPs.
For biodegradation experiments, samples can be provided di-
rectly from a wastewater-treatment plant (WWTP) or a pilot-
scale WWTP (ps-WWTP) or from natural waters [33,34,51].
Moreover, the ability of microorganisms to degrade EPs has been
studied in Erlenmeyer ﬂasks with various microorganisms under
study, such as fungus Trametes versicolor and bacterial Pseudomo-
nas strains [37,40]. Parameters, such as pH, dissolved oxygen (O2),
temperature (T) and total suspended solids (TSS), have to be moni-
tored and adjusted to allow direct comparison with environmental
conditions. In the case of batch reactors seededwith activated sludge
or wastewater, a concentration of 3 g/L of total suspended solids (TSS)
is desirable in order to avoid matrix interferences. During such ex-
periments, spiked and non-spiked samples run in parallel, as do
spiked autoclaved diluted sludge or autoclaved groundwater and
ultrapure water in order to correct for abiotic processes [39]. Samples
are collected periodically so that the reaction kinetics of the analytes
can be determined suﬃciently [33,50].
Whereas the question may arise if the use of batch experi-
ments can simulate the biotransformation of EPs in full-scale
WWTPs, previous studies with batch reactors have proved that,
indeed, biotransformation reactions and kinetics can be observed
reasonably well in a batch reactor [58]. In aerobic conditions, re-
actors are loosely capped and shaken or mixed in order to allow
free transfer of oxygen, while, for anaerobic treatment, the process
is conducted under an atmosphere of N2. Tomaintain anaerobic con-
ditions, the anaerobic chamber is ﬂushed with a mixture of N2/
CO2 gas.
Membrane bioreactors (MBRs), air-pulsed ﬂuidized-bed
bioreactors and sequencing batch reactors (SBRs) [37,50] are more
realistic systems than batch reactors, because they better simu-
late the conditions in the full-scale system.
To assess the principal biodegradability and the formation of po-
tential TPs, tests of the OECD series are referred to in the literature:
• the widely used Closed Bottle test (CBT, OECD 301 D) working
with low bacterial density;
• the manometric respirometry test (MRT, OECD 301 F) working
with medium bacterial density; and,
• the Zahn–Wellens test (ZWT, OECD 302 B) working with high
bacterial density.
The CBT simulates conditions in surface water, while the other
two simulate eﬄuents [38]. However, those OECD tests usually work
at very high concentrations and provide no reaction kinetics.
When preliminary studies in batch experiments are com-
pleted, veriﬁcation of the results should then be carried out using
real environmental samples. However, as concentrations are usually
lower in the environmental systems, analytical methods have to be
adapted. There are few studies with direct injection of environ-
mental samples for the identiﬁcation of TPs. More often, sediments,
activated sludge, wastewater and river-water samples were col-
lected and subjected to solid-phase extraction (SPE) or liquid-
liquid extraction (LLE) prior to analysis, for enrichment of the analytes
[35,44,51]. To achieve suﬃcient enrichment for a broad range of com-
pounds, including TPs with different physical-chemical properties,
Kern et al. used simultaneously four different SPE sorbents in one
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Table 2
Identiﬁed transformation products (TPs) of emerging contaminants formed by abiotic processes (e.g., ozonation, photolysis and chlorination) in water
Parent compound/Group of
substances
Type of study/
Degradation
process
Identiﬁed TPs Toxicity
information
Identiﬁcation workﬂow Ref.
Sample
preparation
Instrumental
technique(s)
Software
(prediction/post
data treatment)
Azithromycin Photodegradation:
Simulated solar
radiation
7 TPs – pathway suggested – – UPLC/ESI-QqToF-MS, UPLC/ESI-
QqQ-MS
Waters MassLynx, mass accuracy,
fragmentation pattern, double-bond
equivalents
[70]
Benzotriazoles Ozonation 11 oxidation TPs (with and
without ring cleavage)
– SPE (Isolute ENV+) HPLC-QTOF, UV-Vis, full scan mode
HPLC-QqQ-MS/MS, HPTLC/AMD
H/D Exchange, Derivatization
experiments
XIC, Agilent MassHunter Workstation,
Molecular Formula Generator,
Molecular Feature Extractor, Mass
Proﬁler Professional
[71]
Chlorpromazine (tricyclic
antipsychotic drug)
Photodegradation:
UV/VIS xenon lamp
28 TPs – – HPLC-UV-Fluorescence-Ion Trap-
MSn
Esquire software, Bruker Metabolite
Tools & Data Analysis, fragmentation &
isotopic pattern
[38]
Cocaine, benzoylecgonine (BE) Hydrolysis,
chlorination,
photodegradation
16 TPs of Cocaine (3 already
known), 10 TPs of BE (1
already known)
– – UPLC-QqToF- MSE, HPLC-QqQ Waters MassLynx, MetaboLynx, XIC,
mass accuracy, fragmentation pattern
[72]
Fenoﬁbric acid Photodegradation:
UV and UV/H2O2
4-chloro-4′-(1-hydroxy-1-
methylethyl) benzophenone, &
minor chlorinated aromatics
TPs
algal growth
inhibition test
using
Pseudokirchneriella
subcapitata
– LC-ESI-QTOF-MS/MS Agilent MassHunter Workstation, mass
accuracy, fragmentation pattern
[6]
Imazalil Ozonation 4 TPs Acute toxicity test
Daphnia magna
– LC- LTQ-Orbitrap-MSn Thermo Xcalibur, XIC, mass accuracy,
fragmentation & isotopic pattern,
retention time plausibility
[5]
Ketoprofen UV irradiation 22 TPs – SPE (Oasis™ HLB) GC-MS, GC-Ion Trap-MS/MS, UPLC-
QqToF-MSn
Agilent Chemstation, Varian MS
Workstation, Waters MassLynx,
MetaboLynx mass accuracy,
fragmentation pattern, elution order,
reference standards, NIST library
[73]
Quinclorac Photolysis,
Photocatalysis
(TiO2)
14 TPs: Pyridine ring
hydroxylation, ring opening
and/or oxidative
dechlorination
– SPE (Oasis™ HLB) HPLC-QTOF-MS/MS Agilent MassHunter, retention time
prediction: ChemBio3D Ultra, mass
accuracy, fragmentation & isotopic
pattern
[74]
8 Triazines (ametryn, atrazine,
cyanazine, metrybuzine,
prometryn, propazin,
simazine, terbutryn)
Chlorination with
sodium
hypochlorite
4 TPs (1 never previously
reported)
Acute toxicity test
Vibrio ﬁscheri: TPs
higher toxicity
On line SPE
(polymeric
cartridge)
HPLC-UV, UPLC-Q-ToF-MS/MS Waters MassLynx, mass accuracy,
fragmentation pattern
[75]
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cartridge (weak anion, weak cation-exchange material, and non-
polar and hydrophilic-lipophilic interaction sorbents) [5].
As identiﬁcation is a time-consuming process and often a great
number of TPs are formed, prioritization of the most relevant TPs
for identiﬁcation and assessment is necessary. There are two main
approaches:
• the effect-directed analysis (EDA); and,
• the exposure-driven approach.
The success of each approach underlies on the selection of the
sample together with the sample preparation.
EDA, which has a toxicological perspective, was ﬁrst intro-
duced for the identiﬁcation of TPs by Escher and Fenner in 2010
[8]. Modiﬁed EDA is based on the relation of the toxicity change of
an environmental sample to the decrease of the parent-compound
concentration, undergoing a transformation process. If increased tox-
icity is observed, then toxic TPs are likely to be formed [8].
Furthermore, the US EPA applies a standardized protocol for tox-
icity identiﬁcation and evaluation (TIE) (www.epa.gov). EDA is a
useful tool to identify non-target and unknown toxicants based on
their effects on the environment. This approach works with step-
wise separation and simpliﬁcation of the sample in order to isolate
components with toxic activity. The manipulations are directed by
bioassays; when toxicity increases, identiﬁcation of the toxic com-
pound through chemical analysis should be performed. The
fractionation approach is a non-selective, non-destructive, clean-
up methodology.
However, the more common approach is exposure driven, where
the TPs are distinguished and singled out for identiﬁcation accord-
ing to their occurrence. As the concentration of the TP gets higher,
it is considered more relevant to risk. This approach is commonly
used in the laboratory studies, followed by environmental fate as-
sessment and toxicity testing [8].
The combination of both approaches is also possible:
• ﬁrst, selection of samples with increased toxicity during trans-
formation; and, subsequently,
• identiﬁcation of the highest concentrated TPs in the sample
without further separation.
4. Identiﬁcation approaches – analytical techniques
Nowadays, liquid chromatography (LC) coupled to MS (LC-MS)
using a variety of mass analyzers is the technique of choice for the
investigation of EPs and TPs in environmental samples.
LC is a suitable chromatographic technique for polar, thermo-
labile compounds, thus for the identiﬁcation of TPs, which are
generally more polar than their parent molecules.
Mass analyzers commonly employed are triple quadrupole (QqQ),
time-of-ﬂight (TOF), ion-trap (IT), Orbitrap and hybrid [e.g., qua-
drupole time-of-ﬂight (Q-TOF), quadrupole-linear ion trap
(Q-LIT), linear ion trap-Orbitrap or quadrupole-Orbitrap].
There are various workﬂows in the literature for the identiﬁca-
tion of TPs, depending indispensably on the instrumentation and
the available software. Fig. 1 shows the main outline:
(a) target analysis, which is based on the determination of already
known TPs, and identiﬁcation is carried out with standard
solutions;
(b) suspect screening, with a list of possible TPs assembled from
the literature or from prediction models, and the samples are
screened for those candidates; and,
Fig. 1. Flow chart of screening procedure of transformation products (TPs). ‘Known’ TPs have been conﬁrmed or conﬁdently identiﬁed before, other TPs are considered
‘Unknown’.
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(c) non-target screening, with identiﬁcation of novel TPs being
carried out with sophisticated post-acquisition data tools and
supplementary analytical techniques.
The development and the use of powerful HR-MS is the driving
force in development of novel analytical methodologies for the iden-
tiﬁcation of TPs. Due to its sensitivity in full-scan acquisition mode
and high mass accuracy, HR-MS is suitable for target and non-
target analysis, pre- and post-acquisition processing, retrospective
analysis and discovery of TPs.
4.1. Target analysis
In target analysis, as shown in Fig. 1, TPs are already known and
standards are available, so that they can be includedwithin a deﬁned
MSmethod and bemonitored in routine analysis. LC coupled to triple
quadrupole (LC-QqQ-MS/MS) is the workhorse in target analysis.
The QqQ analyzer permits application of MS/MSmodes [e.g., product-
ion scan, precursor-ion scan, neutral-loss scan and selected reaction
monitoring (SRM), which is the most predominant]. The SRMmode
provides several advantages and interesting characteristics for target
analysis, such as increased selectivity, reduced interferences and high
sensitivity, which allows robust quantiﬁcation. Another important
point is the possibility of reducing the analysis time, including ex-
traction and instrumental determination.
With the use of LC-QqQ-MS/MS, adequate results have been ob-
tained for the analysis of ECs and the identiﬁcation and the
quantiﬁcation of their TPs, especially in pesticides and pharma-
ceutical compounds, where standards are available.
HR-MS for target analysis offers promising solutions to the limi-
tations of SRM analysis, which allows monitoring of only speciﬁc
TPs. Virtually all compounds present in a sample can be deter-
mined simultaneously with HR-MS instruments operating in full-
scan mode, making it unnecessary to pre-select compounds and
associated SRM transitions. Target compounds included in a data-
base are screened in the sample based on mass accuracy, isotopic
pattern, retention time (tR) and MS/MS fragments. Alternatively,
hybrid instruments offer the possibility of data-dependent MS/MS
acquisition, where MS/MS analysis is triggered if a compound from
a target-ion list is detected in the full scan. Moreover, HR-MS in-
struments can differentiate isobaric compounds with the same
nominal mass but different molecular formula due to their higher
resolving power [3,12,13,15,16].
HR-MS outperforms LR-MS regarding the level of identiﬁcation
of an unknown compound, since, within Decision 2002/657/EC, it
gainsmore identiﬁcation points and can providemass accuracy, even
in full-scan mode. One ion in HR-MS gains two identiﬁcation points,
instead of one in LR-MS, whereas HR-MSn transition products gain
two-and-a-half instead of one-and-a-half. It is clear that in HR-
MS full-scanmode, more than one ion is present in the mass spectra
and evaluated.
4.2. Suspect screening – prediction of transformation products
Suspect screening is the technique of choice for the identiﬁca-
tion of TPs, when the conﬁrmation of the analytes with a reference
standard is impossible, but molecular formula and structure of sus-
pected molecules can be predicted (Fig. 1) [10,13,15,50,51].
In suspect screening, an important step of the identiﬁcationwork-
ﬂow is the prediction of possible TPs using computational (in-
silico) prediction tools. Commercially available or freely accessible
programs have been applied in the prediction step on environmen-
tal analysis, including:
• University of Minnesota Pathway Prediction System (UM-PPS:
http://eawag-bbd.ethz.ch/) [33,34];
• CATABOL (http://oasis-lmc.org/products/models/environmental
-fate-and-ecotoxicity/catabol-301c.aspx);
• PathPred (http://www.genome.jp/tools/pathpred/); and,
• Meteor (http://www.lhasalimited.org/products/meteor
-nexus.htm).
The prediction system should be properly selected by consid-
ering the organism or the system where TPs are formed.
Meteor was built based on mammalian biotransformation re-
actions of common functional groups and allows prediction of the
most probable TPs, providing in parallel relevant literature
references.
PathPred is a multi-step reaction prediction server for biodeg-
radation pathways of xenobiotic compounds and biosynthesis
pathways of secondary metabolites. It is linked to KEGG metabol-
ic pathwaymaps and it has the potential to link the prediction result
to genomic information.
CATABOL and UM-PPS predictmicrobialmetabolic reactions based
on biotransformation rules.
As UM-PPS is freely accessible and all rules applied are clearly
assigned, it is the most common prediction tool in suspect screen-
ing, and many researchers have tried to evaluate and to improve
its prediction power [34,50–52]. The prediction rules behind UM-
PPS come from the University of Minnesota Biocatalysis/
Biodegradation Database (UM-BBD) and literature [85]. Since UM-
BBD has integrated data generated from pure microbial cultures, the
predicted pathways may not be completely appropriate for envi-
ronmental systems [34]. The relatively high false-positive rates of
all prediction systems are of concern, since the inclusion of addi-
tional pathways increases the number of possible degradation
products. In UM-PPS, combinatorial explosion can be limited by pri-
oritizing the different rules using relative reasoning.
Prediction of TPs is followed by the HR-MS analysis; the exact
mass for each of the predicted TPs is extracted from the chromato-
gram and checked by comparing it with control samples. An
intensity-threshold value is applied to cut off unclear spectra. The
plausibility of the chromatographic tR, isotopic pattern, and ion-
ization eﬃciency are used as further ﬁlters to narrow down the
number of candidate peaks. Furthermore, usingMS/MS orMSn, struc-
tures of suspected TPs are suggested based on the observed
fragmentation pattern.
Depending on the above criteria, there are different conﬁdence
levels of identiﬁcation in HR-MS analysis of TPs. When all the above
criteria are fulﬁlled, a probable structure is proposed based on a
library-spectrum match or diagnostic evidence. Otherwise, tenta-
tive candidates or just unequivocal molecular formulas are the
outcome of suspect screening [86].
One approach for processing the data would be the identiﬁca-
tion of key TPs in terms of persistence over the time of the
experiment. It is carried out by a data-processing method that is
established based on peak detection, time-trend ﬁltration and struc-
ture assignment. Open-source software is used for peak peaking
(e.g., MZmine) and processing of the chromatograms (e.g., enviMass),
by noise removal and blank subtraction. Then, a meaningful time
trend is acquired and the remaining candidate peaks are com-
paredwith a list fromUM-PPS or literature for tentative identiﬁcation
[87].
Another approach to suspect screening is based on the use of
characteristic fragmentation undergone by EPs during MS/MS frag-
mentation events [51]. It is based on the assumption that many TPs
maintain a structure similar to the parent compound and there-
fore have common fragment ions. Thus, searching for speciﬁc
fragment ions in MS/MS spectra throughout the chromatographic
run could lead to new TPs. This is evident when applying product-
ion and neutral-loss scans, and other techniques, such as mass-
defect ﬁltering.
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4.3. Non-target screening
Non-target screening implies the identiﬁcation of compounds
for which there is no previous knowledge available and is usually
carried out after target and suspect screening. Non-target screen-
ing becomes a challenging task, but, for TPs, further information of
the parent compound (e.g., molecular formula, MS/MS spectrum,
tR and other physico-chemical data) may contribute to further
ranking of possible structures and facilitate the identiﬁcation process
[68]. For non-target screening, HR-MS is strongly required in order
to have mass accuracy for conﬁrmation of the molecular formula
and reliable interpretation of the MS/MS spectra [13,14].
The challenge with HR instruments is the generation of
massive quantities of data and subsequently their evaluation and
the export of results. Moreover, their ability to operate in full-
scan and MS/MS modes simultaneously provides even more data
in a single run. For this reason, post-acquisition data-processing
tools are necessary; computer-aided techniques provide rapid, ac-
curate and eﬃcient data mining. There is a number of open-
source and commercial software options for non-target screening,
including:
• MZmine (http://mzmine.sourceforge.net/);
• XCMS (https://xcmsonline.scripps.edu);
• EnviMass (http://www.eawag.ch/forschung/uchem/software/
enviMass1);
• Non-target, ACD MS/Workbook Suite; and,
• vendors’ software, such as Bruker Metabolite Tools and
ProﬁleAnalysis, Waters MassLynx and MetaboLynx, Thermo Sci-
entiﬁc Metworks and Sieve, Applied Biosystems Data Explorer
(MDS-Sciex Analyst QS) and Agilent MassHunter.
The general procedure, as shown in Fig. 1, has several steps until
it reaches the ﬁnal result, which does not follow the same order in
each software or workﬂow.
The ﬁrst step is always peak picking. In this step, comparison of
the sample with control or blank samples is important to exclude
irrelevant peaks.
The removal of noise peaks, mass recalibration and
componentization of isotopes and adducts is usually carried out au-
tomatically as the next step.
The assignment of the molecular formula to the accurate mass
of the peak is performed using heuristic ﬁlters, such as the seven
golden rules of Kind and Fiehn [88].
Exploration of databases, such as ChemSpider, PubChem, DAIOS
database, NIST or structure generation, may lead to candidate struc-
tures [89,90]. Thereby, information on the parent compound (e.g.,
molecular formula, substructures) can help to restrict the search of
databases and possible structures are likely to be proposed for the
compound. However, databases contain mostly only EPs, but many
TPs are not included yet.
One successful example of the application of a non-target work-
ﬂow is the identiﬁcation of biotransformation products of three
benzotriazoles [36].
Even after ﬁltering, strict criteria and thresholds in the above pa-
rameters, the number of peaks, which correspond to non-targets
can exceed 1000. It is clear that elucidation of all those peaks would
demand a great amount of time and effort; prioritization of the most
intense peaks is a common strategy [91].
Similar to suspect screening, the observation of the presence or
the absence of common characteristic ions in the fragmentation
pattern of both the parent compound and the TPs, evidencing the
stability or reactivity of certain parts of the molecule, can be helpful
[3].
For ranking the candidate structures, information from MS/MS
spectra has to be explored by comparing the fragmentation pattern
with in-silico mass spectral fragmentation or with spectra in librar-
ies. There are a few databases with mass spectra, e.g.:
• MassBank (http://massbank.ufz.de/MassBank/); and,
• MetLin (http://metlin.scripps.edu/index.php).
However, most software do not take into account the fragmen-
tation pattern. MOLGEN-MS (http://www.molgen.de/), ACD/MS
Fragmenter (www.acdlabs.com/products/adh/ms/ms_frag) and
MassFrontier (www.highchem.com/index.php/massfrontier) use frag-
mentation rules, whereas MetFrag offers a purely combinatorial
approach based on bond energies only. Although the overall can-
didate ranking with MetFrag is not quite as good as that obtained
with Mass Frontier and MOLGEN-MS, the scoring function used in
MetFrag can improve the ranking signiﬁcantly (http://
msbi.ipb-halle.de/MetFrag/).
MetFusion, the newest development, combines MetFrag with
spectral database searching (http://msbi.ipb-halle.de/MetFusion/).
The use of fragmentation trees as performed in SIRIUS is another
approach for the structure elucidation (http://bio.informatik
.uni-jena.de/sirius2/).
In any case, criteria must be established for the success of the
identiﬁcation of the TP by the accuracy of the molecular ion (e.g.,
mass error < 5 ppm, dependent on the mass accuracy) and the char-
acteristic fragment ions in MS/MS mode (purity score ≥ 65
recommended) [3].
Criteria also exist for the score of the isotopic pattern in most
commercial software.
Müller et al. proposed another approach for non-target screen-
ing of TPs, focusing on relevant peaks (features). The sample is not
regarded as an isolated specimen, but is rather evaluated in rela-
tion to a set of other samples based on considerations of, e.g., their
temporal, spatial, or process-related connections. This also covers
comparison of assays and controls, as carried out in evaluation of
many transformation experiments. The features of the sample are
considered as mathematical sets and treated with statistical tools
[90].
Finally, orthogonal analytical approaches are frequently crucial
for the successful unambiguous identiﬁcation of TPs. Nuclear mag-
netic resonance (NMR) is one option for a complementary technique
for identiﬁcation and conﬁrmation of TP structures as long as suf-
ﬁcient quantities can be isolated [33,39].
5. Future needs and trends
Development of generic and retrospective analytical tech-
niques should permit the simultaneous determination of parent
compounds and their TPs, within a single run. In the identiﬁca-
tion of TPs, the future lies in tiered approaches, which employ
HR-MS, complementary techniques and advanced software tools.
HR-MS outperforms LR-MS, regarding the level of identiﬁcation of
an unknown compound. Moreover, identiﬁcation by HR-MS anal-
ysis has different levels of conﬁdence, regarding the supporting
evidence recorded, apart from the molecular ion {e.g., MSn or library
match [86]}.
However, we are at an early stage in studying the identiﬁca-
tion of TPs and the workﬂows applied, as instrumentation and
software are still in progress and are getting more complete and
easier to use. Speciﬁc, step-wise, automated workﬂows that take
into consideration the advantages of HR-MS instruments are still
missing for suspect and non-target analysis. Exclusion parameters
and suﬃcient ﬁltering are necessary for the prioritization of peaks
and elimination of false-positive and false-negative results. In amore
integrated workﬂow, prediction models should also be combined
and propose TPs from the whole range of transformation rules and
automatically integrate them in subsequent suspect screening.
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Non-target screening should be an extra step for elucidating the rest
of the unknown peaks, evaluating not only the most intense, but
ideally the most relevant, also according to ecotoxicity. Therefore,
new computational tools for toxicity prediction or coupling with
high-throughput toxicity tests would be preferable.
Moreover, a universal tR prediction model, which does not need
unreasonable efforts for calibration and takes into consideration
neutral and ionic compounds, would contribute a lot in further eval-
uation of the data [32]. A gap also exists for in-silico fragmentation
models, lacking mainly in giving fragments, reasonable for each ion-
ization mode and according to speciﬁc rules.
However, deﬁnite identiﬁcation can be performed only using ref-
erence standards, and is diﬃcult because, in most cases, reference
standards are not commercially available. Additional and supple-
mentary orthogonal techniques (e.g., NMR, different MS techniques
or other analytical or separation techniques) could contribute in the
structure elucidation of unknown TPs, and in conﬁrmation. In this
way, multiple physicochemical properties of the compound would
be taken into account [92]. Although, most non-target com-
pounds reported are not fully identiﬁed, their communication in
the scientiﬁc community is of great importance, especially if the
results are accompanied by an uncertainty or a conﬁdence level [92].
Despite the demands for an identiﬁcation process, sample prep-
aration should not be forgotten, since environmental samples are
complicated matrices and TPs are expected at very low concentra-
tions. It is clear that sample preparation is very challenging in order
to capture the wide range of polarities of the potential TPs and to
take full advantage of the analytical instruments but, at the same
time, to eliminate interfering matrix components.
Summing up, researchers, scientists and policy makers still have
a long way to go in order to explore the ﬁeld of TPs of EPs and to
perform an integrated risk assessment. Research is ongoing on the
development of high-throughput techniques, including extrac-
tion, analysis and data-evaluation steps.
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